UBS Group »

Revolution Medicines shares owned by UBS Group

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.8M 307k 28.68
2023-09-30 $2.7M 97k 27.68
2023-06-30 $3.7M 137k 26.75
2023-03-31 $3.0M 138k 21.66
2022-12-31 $4.0M 168k 23.82
2022-09-30 $649k 33k 19.83
2022-06-30 $800k 41k 19.49
2022-03-31 $2.3M 90k 25.83
2021-12-31 $2.9M 114k 25.10
2021-09-30 $3.2M 117k 27.48
2021-06-30 $37k 1.1k 33.33
2021-03-31 $66k 1.4k 45.96
2020-12-31 $48k 1.2k 39.90
2020-06-30 $154k 4.9k 31.48
2020-03-31 $183k 8.4k 21.86